PT Bio Farma (Persero) stated that it was ready to process 15 million doses of the Covid-19 vaccine raw material from Sinovac, which were brought using nine envirotainers. The final products in the form of the Covid-19 vaccines are named Cov2Bio and Covid-19.

"The raw materials received by Bio Farma will then be processed into the final product in the form of Covid-19 vaccines under the names Cov2Bio and Covid-19. The raw materials will be processed at the filling and finishing facility in Bio Farma, "said Bio Farma Corporate Secretary, Bambang Heriyanto, via a press release, Wednesday (13/1).